During the past decade, Hospital for Joint Diseases MS Care Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital for Joint Diseases MS Care Center" #1 sponsor was "Alexion" with 2 trials, followed by "Avanir Pharmaceuticals" with 2 trials sponsored, "NYU Langone Health" with 2 trials sponsored, "Acorda Therapeutics" with 1 trials sponsored and "Actelion" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital for Joint Diseases MS Care Center" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital for Joint Diseases MS Care Center" are "Multiple Sclerosis" (7 trials), "Neuromyelitis Optica" (2 trials), "Neuromyelitis Optica Spectrum Disorder" (2 trials), "Alzheimer's Disease" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Hospital for Joint Diseases MS Care Center" in a lesser frequency.

Most popular intervention types in "Hospital for Joint Diseases MS Care Center" are "Drug" (10 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AVP-923" (2 trials), "Avonex prefilled syringe via manual IM injection" (1 trials), "BG9418 (interferon beta-1a)" (1 trials) and "Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital for Joint Diseases MS Care Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Hospital for Joint Diseases MS Care Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hospital for Joint Diseases MS Care Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital for Joint Diseases MS Care Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".